A. Mckeon, M. Frye, and N. Delanty, The alcohol withdrawal syndrome, Journal of Neurology, Neurosurgery & Psychiatry, vol.79, issue.8, pp.854-862, 2008.
DOI : 10.1136/jnnp.2007.128322

R. Ward, F. Lallemand, and P. De-witte, Biochemical and Neurotransmitter Changes Implicated in Alcohol-Induced Brain Damage in Chronic or 'Binge Drinking' Alcohol Abuse, Alcohol and Alcoholism, vol.44, issue.2, pp.128-163, 2009.
DOI : 10.1093/alcalc/agn100

C. Fowler, M. Rojo, and A. Rodriguez-gaztelumendi, Modulation of the endocannabinoid system: Neuroprotection or neurotoxicity?, Experimental Neurology, vol.224, issue.1, pp.37-47, 2010.
DOI : 10.1016/j.expneurol.2010.03.021

A. Hampson, L. Bornheim, M. Scanziani, C. Yost, and A. Gray, Dual Effects of Anandamide on NMDA Receptor-Mediated Responses and Neurotransmission, Journal of Neurochemistry, vol.70, issue.2, pp.671-677, 1998.
DOI : 10.1046/j.1471-4159.1998.70020671.x

D. Fernández-lópez, J. Martínez-orgado, E. Nuñ-ez, J. Romero, and P. Lorenzo, Characterization of the Neuroprotective Effect of the Cannabinoid Agonist WIN-55212 in an In Vitro Model of Hypoxic-Ischemic Brain Damage in Newborn Rats, Pediatric Research, vol.54, issue.2, pp.169-73, 2006.
DOI : 10.1203/01.pdr.0000228839.00122.6c

G. Gilbert, H. Kim, J. Waataja, and S. Thayer, ??9-Tetrahydrocannabinol protects hippocampal neurons from excitotoxicity, Brain Research, vol.1128, pp.61-70, 2007.
DOI : 10.1016/j.brainres.2006.03.011

R. Pertwee and R. Ross, Cannabinoid receptors and their ligands, Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA), vol.66, issue.2-3, pp.101-122, 2002.
DOI : 10.1054/plef.2001.0341

V. Warnault, H. Houchi, E. Barbier, O. Pierrefiche, and C. Vilpoux, The lack of CB1 receptors prevents neuroadapatations of both NMDA and GABAA receptors after chronic ethanol exposure, Journal of Neurochemistry, vol.52, issue.3, pp.741-52, 2007.
DOI : 10.1111/j.1471-4159.2007.04577.x

URL : https://hal.archives-ouvertes.fr/inserm-00746175

J. Nagy, F. Müller, and L. László, Cytotoxic effect of alcohol-withdrawal on primary cultures of cortical neurones, Drug and Alcohol Dependence, vol.61, issue.2, pp.155-62, 2001.
DOI : 10.1016/S0376-8716(00)00132-0

K. Vinod, S. Kassir, B. Hungund, T. Cooper, J. Mann et al., Selective alterations of the CB1 receptors and the fatty acid amide hydrolase in the ventral striatum of alcoholics and suicides, Journal of Psychiatric Research, vol.44, issue.9, pp.591-598, 2010.
DOI : 10.1016/j.jpsychires.2009.11.013

J. Nagy and L. Laszlo, Increased sensitivity to NMDA is involved in alcohol-withdrawal induced cytotoxicity observed in primary cultures of cortical neurones chronically pre-treated with ethanol, Neurochemistry International, vol.40, issue.7, pp.585-591, 2002.
DOI : 10.1016/S0197-0186(01)00131-0

C. Harper, The Neuropathology of Alcohol-Related Brain Damage, Alcohol and Alcoholism, vol.44, issue.2, pp.136-176, 2009.
DOI : 10.1093/alcalc/agn102

D. Witte, P. Pinto, E. Ansseau, M. Verbanck, and P. , Alcohol and withdrawal: from animal research to clinical issues, Neuroscience & Biobehavioral Reviews, vol.27, issue.3, pp.189-197, 2003.
DOI : 10.1016/S0149-7634(03)00030-7

P. Maccioni, G. Colombo, and M. Carai, Blockade of the Cannabinoid CB1 Receptor and Alcohol Dependence: Preclinical Evidence and Preliminary Clinical Data, CNS & Neurological Disorders - Drug Targets, vol.9, issue.1, pp.55-64, 2010.
DOI : 10.2174/187152710790966623

J. Fernández-ruiz, The endocannabinoid system as a target for the treatment of motor dysfunction, British Journal of Pharmacology, vol.276, issue.1074, pp.1029-1069, 2009.
DOI : 10.1111/j.1476-5381.2008.00088.x

M. Shen and S. Thayer, Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity, Mol Pharmacol, vol.54, pp.459-62, 1998.

S. Zhuang, D. Bridges, E. Grigorenko, S. Mccloud, and A. Boon, Cannabinoids produce neuroprotection by reducing intracellular calcium release from ryanodine-sensitive stores, Neuropharmacology, vol.48, issue.8, pp.1086-96, 2005.
DOI : 10.1016/j.neuropharm.2005.01.005

J. Rivers and J. Ashton, The Development of Cannabinoid CBII Receptor Agonists for the Treatment of Central Neuropathies, Central Nervous System Agents in Medicinal Chemistry, vol.10, issue.1, pp.47-64, 2010.
DOI : 10.2174/187152410790780145

F. Docagne, V. Muñ-etó-n, D. Clemente, C. Ali, F. Loría et al., Excitotoxicity in a chronic model of multiple sclerosis: Neuroprotective effects of cannabinoids through CB1 and CB2 receptor activation, Molecular and Cellular Neuroscience, vol.34, issue.4, pp.551-61, 2007.
DOI : 10.1016/j.mcn.2006.12.005

B. Basavarajappa and B. Hungund, Chronic Ethanol Increases the Cannabinoid Receptor Agonist Anandamide and Its Precursor N-Arachidonoylphosphatidylethanolamine in SK - N - SH Cells, Journal of Neurochemistry, vol.19, issue.2, pp.522-530, 1999.
DOI : 10.1046/j.1471-4159.1999.0720522.x

B. Basavarajappa and B. Hungund, Neuromodulatory role of the endocannabinoid signaling system in alcoholism: an overview, Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA), vol.66, issue.2-3, pp.287-299, 2002.
DOI : 10.1054/plef.2001.0352

B. Basavarajappa, M. Saito, T. Cooper, and B. Hungund, Chronic ethanol inhibits the anandamide transport and increases extracellular anandamide levels in cerebellar granule neurons, European Journal of Pharmacology, vol.466, issue.1-2, pp.73-83, 2003.
DOI : 10.1016/S0014-2999(03)01557-7

S. González, M. Cascio, J. Fernández-ruiz, F. Fezza, D. Marzo et al., Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine, Brain Research, vol.954, issue.1, pp.73-81, 2002.
DOI : 10.1016/S0006-8993(02)03344-9

S. González, M. Valenti, D. Miguel, R. Fezza, F. Fernández-ruiz et al., Changes in endocannabinoid contents in reward-related brain regions of alcohol-exposed rats, and their possible relevance to alcohol relapse, British Journal of Pharmacology, vol.61, issue.4, pp.455-64, 2004.
DOI : 10.1038/sj.bjp.0705963

D. Choi, Excitotoxic cell death, Journal of Neurobiology, vol.68, issue.9, pp.1261-1276, 1992.
DOI : 10.1002/neu.480230915

Q. Liu, M. Bhat, W. Bowen, and J. Cheng, Signaling Pathways from Cannabinoid Receptor-1 Activation to Inhibition of N-Methyl-D-Aspartic Acid Mediated Calcium Influx and Neurotoxicity in Dorsal Root Ganglion Neurons, Journal of Pharmacology and Experimental Therapeutics, vol.331, issue.3, pp.1062-70, 2009.
DOI : 10.1124/jpet.109.156216

M. Rubio, D. Mchugh, J. Fernández-ruiz, H. Bradshaw, and J. Walker, Short-term exposure to alcohol in rats affects brain levels of anandamide, other N-acylethanolamines and 2-arachidonoyl-glycerol, Neuroscience Letters, vol.421, issue.3, pp.270-274, 2007.
DOI : 10.1016/j.neulet.2007.05.052

K. Vinod, P. Maccioni, M. Garcia-gutierrez, T. Femenia, S. Xie et al., Innate difference in the endocannabinoid signaling and its modulation by alcohol consumption in alcohol-preferring sP rats, Addiction Biology, vol.267, issue.1, 2011.
DOI : 10.1111/j.1369-1600.2010.00299.x

G. Colombo, A. Orrù, P. Lai, C. Cabras, and P. Maccioni, The Cannabinoid CB1 Receptor Antagonist, Rimonabant, as a Promising Pharmacotherapy for Alcohol Dependence: Preclinical Evidence, Molecular Neurobiology, vol.183, issue.Suppl, pp.102-114, 2007.
DOI : 10.1007/s12035-007-0017-y

M. Soyka, G. Koller, P. Schmidt, O. Lesch, and M. Leweke, Cannabinoid Receptor 1 Blocker Rimonabant (SR 141716) for Treatment of Alcohol Dependence, Journal of Clinical Psychopharmacology, vol.28, issue.3, pp.317-341, 2008.
DOI : 10.1097/JCP.0b013e318172b8bc

D. George, D. Herion, C. Jones, M. Phillips, and J. Hersh, Rimonabant (SR141716) has no effect on alcohol self-administration or endocrine measures in nontreatment-seeking heavy alcohol drinkers, Psychopharmacology, vol.33, issue.1, pp.37-44, 2010.
DOI : 10.1007/s00213-009-1704-3

O. Nicole, F. Docagne, C. Ali, I. Margaill, and P. Carmeliet, The proteolytic activity of tissue-plasminogen activator enhances NMDA receptormediated signaling, Nat Med, vol.7, pp.59-64, 2001.